TG Therapeutics

CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
EMA
Europe
CHMP
Wegovy
Novo Nordisk
Bimervax
TG Therapeutics
Eli Lilly
Bristol Myers Squibb
Novartis
AstraZeneca
Flag link:
FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022
FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022
BioPharma Dive
FDA
drug approvals
HIV
lymphoma
multiple sclerosis
Gilead Sciences
Roche
TG Therapeutics
Flag link:
Go or no go? Mirati heads to the FDA
Go or no go? Mirati heads to the FDA
EP Vantage
FDA
Mirati Therapeutics
Gilead Sciences
Coherus Biosciences
Roche
Biogen
TG Therapeutics
Ipsen
Novartis
BeiGene
Cytokinetics
Flag link:
ICER on MS drugs: TG's ublituximab not cost effective at the same price as Roche's ocrelizimab
ICER on MS drugs: TG's ublituximab not cost effective at the same price as Roche's ocrelizimab
Endpoints
ICER
MS
multiple sclerosis
drug pricing
ublituximab
TG Therapeutics
Flag link:
Brace for an end-of-year boost to drug approvals
Brace for an end-of-year boost to drug approvals
EP Vantage
FDA
drug approvals
Alnylam Pharmaceuticals
Apellis Pharmaceuticals
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
Mirati Therapeutics
Moderna Therapeutics
Provention Bio
Roche
TG Therapeutics
Travere Therapeutics
Flag link:
FDA withdraws cancer drug approval after finding possible higher death rates
FDA withdraws cancer drug approval after finding possible higher death rates
RAPS.org
TG Therapeutics
clinical trials
Ukoniq
cancer
Flag link:
TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment
TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment
BioSpace
TG Therapeutics
ublituximab-umbralisib
chronic lymphocytic leukemia
small lymphocytic lymphoma
Flag link:
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals
Flag link:
TG slips out a nasty surprise for investors
TG slips out a nasty surprise for investors
EP Vantage
TG Therapeutics
FDA
CLL
clinical hold
Flag link:
Samsung Biologics and TG Therapeutics expand blood cancer partnership
Samsung Biologics and TG Therapeutics expand blood cancer partnership
Biopharma Reporter
TG Therapeutics
Samsung BioLogics
ublituximab
monoclonal antibodies
Flag link:
TG Therapeutics completes FDA filing for Roche challenger in CLL
TG Therapeutics completes FDA filing for Roche challenger in CLL
Pharmaforum
TG Therapeutics
FDA
antibodies
CLL
ublituximab-umbralisib
Flag link:
Watch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rivalrnings season continues to show COVID-19 uncertainty
Watch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rivalrnings season continues to show COVID-19 uncertainty
Fierce Pharma
TG Therapeutics
FDA
Ukoniq
umbralisib
follicular lymphoma
marginal zone lymphoma
Gilead Sciences
Flag link:
Mark Your Calendar For February PDUFA Dates
Mark Your Calendar For February PDUFA Dates
Yahoo/Benzinga
FDA
Adamas Pharmaceuticals
Gocovri
Mallinckrodt
StrataGraft
Regeneron
evinacumab
Sanofi
Sarepta
TG Therapeutics
Flag link:
Go or no go? Oncology decisions ahead for the FDA
Go or no go? Oncology decisions ahead for the FDA
EP Vantage
FDA
cancer
oncology
Bristol-Myers Squibb
TG Therapeutics
Mallinckrodt
Sanofi
Regeneron
Sarepta Therapeutics
GSK
Oncopeptide
Flag link:
10 Biopharma Stories to Look Forward to in 2021
10 Biopharma Stories to Look Forward to in 2021
BioSpace
pandemic
COVID-19
vaccines
Joe Biden
drug pricing
M&A
venture capital
JNJ
Biomarin
Bluebird Bio
TG Therapeutics
Biogen
AstraZeneca
Flag link:
TG Therapeutics set for upsized IPO to develop cancer combination drug
TG Therapeutics set for upsized IPO to develop cancer combination drug
Pharmaforum
TG Therapeutics
ASH2020
IPOs
CLL
Flag link:
TG adds a multiple sclerosis string to its bow
TG adds a multiple sclerosis string to its bow
EP Vantage
TG Therapeutics
hematology
ASH2020
ublituximab
MS
multiple sclerosis
Flag link:
FDA to decide on TG Therapeutics’ lymphoma drug early next year
FDA to decide on TG Therapeutics’ lymphoma drug early next year
Pharmaforum
TG Therapeutics
FDA
lymphoma
umbralisib
Bristol-Myers Squibb
Roche
Flag link:
The crucial data readouts coming soon for small biotechs
The crucial data readouts coming soon for small biotechs
EP Vantage
clinical trials
Akebia
Blueprint Medicines
Genfit
TG Therapeutics
vadadustat
Ayvakit
elafibranor
Flag link:
Biotech's Most Volatile Binary Events for Q1
Biotech's Most Volatile Binary Events for Q1
Motley Fool
FDA
Esperion Therapeutics
Karyopharm
TG Therapeutics
Heron Therapeutics
Flag link:

Pages